These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10583234)

  • 1. Enhanced retroviral gene transfer into CML and normal bone marrow, and CML and mobilized peripheral blood CD34+ cells using the recombinant fibronectin fragment CH-296.
    Garrett E; Garin MI; Miller AR; Goldman JM; Melo JV; Apperley JF
    Br J Haematol; 1999 Nov; 107(2):401-8. PubMed ID: 10583234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 30/35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors.
    Traycoff CM; Srour EF; Dutt P; Fan Y; Cornetta K
    Leukemia; 1997 Jan; 11(1):159-67. PubMed ID: 9001433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells.
    Hanenberg H; Hashino K; Konishi H; Hock RA; Kato I; Williams DA
    Hum Gene Ther; 1997 Dec; 8(18):2193-206. PubMed ID: 9449373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor.
    Kiem HP; Andrews RG; Morris J; Peterson L; Heyward S; Allen JM; Rasko JE; Potter J; Miller AD
    Blood; 1998 Sep; 92(6):1878-86. PubMed ID: 9731044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs.
    Goerner M; Bruno B; McSweeney PA; Buron G; Storb R; Kiem HP
    Blood; 1999 Oct; 94(7):2287-92. PubMed ID: 10498600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells.
    Takiyama N; Mohney T; Swaney W; Bahnson AB; Rice E; Beeler M; Scheirer-Fochler S; Ball ED; Barranger JA
    Eur J Haematol; 1998 Jul; 61(1):1-6. PubMed ID: 9688285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroma-conditioned medium and sufficient prestimulation improve fibronectin fragment-mediated retroviral gene transfer into human primitive mobilized peripheral blood stem cells through effects on their recovery and transduction efficiency.
    Breems DA; Van Driel EM; Hawley RG; Siebel KE; Ploemacher RE
    Leukemia; 1998 Jun; 12(6):951-9. PubMed ID: 9639425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.
    Verfaillie CM; Bhatia R; Steinbuch M; DeFor T; Hirsch B; Miller JS; Weisdorf D; McGlave PB
    Blood; 1998 Sep; 92(5):1820-31. PubMed ID: 9716614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
    Dunbar CE; Kohn DB; Schiffmann R; Barton NW; Nolta JA; Esplin JA; Pensiero M; Long Z; Lockey C; Emmons RV; Csik S; Leitman S; Krebs CB; Carter C; Brady RO; Karlsson S
    Hum Gene Ther; 1998 Nov; 9(17):2629-40. PubMed ID: 9853529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
    Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion and characterisation of CD34+ cells derived from chronic myeloid leukaemia bone marrow and peripheral blood, and from normal bone marrow and mobilised peripheral blood.
    Garin MI; Apperley JF; Melo JV
    Eur J Haematol; 2000 Feb; 64(2):85-92. PubMed ID: 10997328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
    Walsh CE; Mann MM; Emmons RV; Wang S; Liu JM
    J Investig Med; 1995 Aug; 43(4):379-85. PubMed ID: 7552587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragments.
    Trarbach T; Greifenberg S; Bardenheuer W; Elmaagacli A; Hirche H; Flasshove M; Seeber S; Moritz T
    Cytotherapy; 2000; 2(6):429-38. PubMed ID: 12044223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells.
    Schiedlmeier B; Buss EC; Veldwijk MR; Zeller WJ; Fruehauf S
    Hum Gene Ther; 1999 Jun; 10(9):1443-52. PubMed ID: 10395370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood.
    Campain JA; Terrell KL; Tomczak JA; Shpall EJ; Hami LS; Harrison GS
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):273-81. PubMed ID: 9450923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture.
    Murray L; Luens K; Tushinski R; Jin L; Burton M; Chen J; Forestell S; Hill B
    Hum Gene Ther; 1999 Jul; 10(11):1743-52. PubMed ID: 10446914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral gene transfer into cord blood stem/progenitor cells using purified vector stocks.
    Asch J; Weinberg RS; Mueller L; Galperin Y; Kiang L; Jolly D; Isola LM
    Am J Hematol; 1998 Jan; 57(1):16-23. PubMed ID: 9423811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.